Goed Method
Goed Method
Omega-3 DHA
Omega-3 EPA
Omega-3 DHA & EPA
DEFINITION
Omega-3 fatty acids, EPA and DHA, consist of the all cis forms of 5, 8, 11, 14, 17-eicosapentaenoic
acid and 4, 7, 10, 13, 16, 19-docosahexaenoic acid, respectively. Omega-3 fatty acid products may be
found with DHA as the predominant fatty acid, EPA as the predominant fatty acid or mixtures of DHA
and EPA in varying combinations.
The content of omega-3 EPA and DHA is expressed as free fatty acid equivalents on a weight/weight
basis, as mg EPA per gram or mg DHA per gram when available as single sources of omega-3. If a
mixture of EPA and DHA exist in the product, the total omega-3 EPA and DHA content may be ex-
pressed individually and as total mg EPA and DHA per gram.
Food approved antioxidant may be added to enhance omega-3 EPA, omega-3 DHA, and omega-3 EPA
and DHA product stability.
SCOPE
Applicable to omega-3 EPA and DHA fatty acids obtained from fish, plant, or microbial sources. Not
applicable to cod liver oil. Omega-3 EPA and DHA may be found esterified as triglycerides, re-
esterified as glycerides, or esterified as ethyl esters. Not applicable to free fatty acid product forms.
Applicable to bulk oil product and encapsulated oil intended for use as dietary supplements. Not appli-
cable to formulations, specialty delivery systems, and EPA and DHA concentrates >80% wt/wt. The
specifications described herein apply throughout the stated lifetime (shelf-life) of the product.
CHARACTERISTICS
Long chain omega-3 EPA and DHA products are generally liquids at ambient temperature. The color
varies from pale, light-yellow to orange. The products have a characteristic odor ranging from bland to
mild fish-like.
IDENTIFICATION
Examine the chromatograms obtained in the assay for long chain omega-3 EPA and DHA. The pres-
ence of EPA and/or DHA based on retention time comparison to authentic reference standards estab-
lishes the identity of the product.
1
TESTS
PCBs. Total PCBs should be expressed on a weight/weight basis and should include IUPAC
congeners 28, 52, 101, 118, 138, 153 and 180
Maximum: 0.09 mg/kg
Dioxin- like PCBs Maximum 3 pg WHO –TEQ/g (maximum for Dioxin and Furans remains at 2
pg/g).
Sample preparation and appropriate methods of analysis for PCDDs, PCDFs, and PCBs are described
in draft European Commission Directive “laying down the sampling methods and the methods of
analysis for the official control of dioxins and the determination of dioxin-like PCBs in foodstuffs”.
Annex II of this document describes appropriate methods of analysis along with a specific list of
PCDD, PCDF and PCB congeners to be included in the calculation. Gas chromatography coupled with
high-resolution mass spectrometry has proved to provide required sensitivity and specificity. Identifica-
tion of congeners should be performed according to EPA Method 1613 revision B: Tetra- through octa-
chlorinated dioxins and furans by isotope dilution HRGC/HRMS or similar.
Heavy Metals.
Note: The maximum intake of PCDDs, PCDFs, PCBs, other pesticides, and heavy metals in various
parts of the world are based on Maximum Allowable Daily Levels (MADL) instead of absolute
amounts in oil; therefore, appropriate consideration should be given to recommended daily serving and
intake.
2
ASSAY
The assay used for quantitative determination of EPA and DHA content in omega-3 products is appli-
cable to triglyceride and ethyl ester product forms with results expressed as mg DHA/g and mg EPA/g
after correction to free fatty acid equivalents.
EPA and DHA. Carry out the operations as rapidly as possible, avoiding exposure to actinic light,
oxidizing agents, oxidation catalysts (for example, copper and iron) and air.
Gas chromatography.
The assay is carried out on the methyl or ethyl esters of all-cis-eicosa-5,8,11,14,17-pentaenoic acid
(EPA; 20:5 n-3) and all-cis-docosa-4,7,10,13,16,19-hexaenoic acid (DHA; 22:6 n-3) in the sample to
be examined.
Internal standard. Methyl tricosanoate R.
1. Dissolve the sample to be examined according to the table below and about 70.0 mg of the internal
standard in a 0.05 g/l solution of butylhydroxytoluene R in trimethylpentane R and dilute to 10.0 ml
with the same solution.
Ethyl esters are now ready for analysis. For triglycerides continue as described in 2.
2. Introduce 2.0 ml of the solution obtained from step 1 into a quartz tube and evaporate the solvent at
40-50°C with a gentle current of nitrogen R. Add 1.5 ml of a 20 g/l solution of sodium hydroxide R in
methanol R, cover with nitrogen R, cap tightly with a polytetrafluoroethylene-lined cap, mix and heat
on a steaming water-bath for 7 min. Allow to cool to 40-50°C.
3. Add 2 ml of boron trichloride-methanol solution R, cover with nitrogen R, cap tightly, mix and heat
on a water-bath for 30 min. Cool to 40-50°C, add 1 ml of trimethylpentane R, cap and shake vigorously
for at least 30 s. Immediately add 5 ml of a saturated solution of sodium chloride R, cover with nitro-
gen R, cap and shake vigorously for at least 15 s. Transfer the upper layer to a separate tube. Shake the
methanol layer once more with 1 ml of trimethylpentane R. Wash the combined trimethylpentane ex-
tracts with 2 quantities, each of 1 ml, of water R and dry over anhydrous sodium sulphate R.
Test solution (b). (to be prepared at the same time as test solution (a))
3
Dissolve 0.300 g of the sample to be examined in a 0.05 g/l solution of butylhydroxytoluene R in
trimethylpentane R and dilute to 10.0 ml with the same solution. Proceed as described for test solution
(a).
Reference solution (a). Prepare 3 individual solutions (to be prepared at the same time as test solution
(a))
Dissolve 60.0 mg of docosahexaenoic acid ethyl ester CRS, about 70.0 mg of the internal standard and
90.0 mg of eicosapentaenoic acid ethyl ester CRS in a 0.05 g/l solution of butylhydroxytoluene R in
trimethylpentane R and dilute to 10.0 ml with the same solution. For analysis of ethyl esters the solu-
tions are now ready for analysis. For analysis of triglycerides continue as described in step 2 for prepa-
ration of test solution (a).
Reference solution (b).(for system suitability of recovery vs. the theoretical response of the Flame
Ionisation Detector (FID))
Introduce 0.3 g of methyl palmitate R, 0.3 g of methyl stearate R, 0.3 g of methyl arachidate R and 0.3
g of methyl behenate R into a 10 ml volumetric flask, dissolve in a 0.05 g/l solution of butylhydroxy-
toluene R in trimethylpentane R and dilute to 10.0 ml with the same solution.
Introduce a sample containing about 55.0 mg docosahexaenoic acid methyl ester CRS and about 5.0
mg of 15-tetracosenoic acid methyl ester CRS diluted to 10.0 ml of a 0.05 g/l solution of butylhydroxy-
toluene R in trimethylpentane R.
Column:1
— material: fused silica
— dimensions: l = at least 25 m, Ø = 0.25 mm,
— stationary phase: bonded polyethylene glycol polymer (film thickness 0.2 µm).
Carrier gas: hydrogen for chromatography R or helium for chromatography.
Split: 1:200, alternatively splitless with temperature control (samples need to be diluted 1:200 with a
0.05 g/l solution of butylhydroxytoluene R in trimethylpentane R before injection)
1
CP-Wax 52CB, 25 m x 0.25 mm I.D. 0.2. µm film thickness, Chrompack cat. no. 7713 or equivalent will be suitable
4
Temperature:
Time Temperature
(min) (°C)
Column 0–2 170
Calculate the content of EPA and DHA as mg fatty acid/g oil using the following expression and tak-
ing into account the certified value of the reference substances. The results should be rounded to the
nearest 10 mg/g based on the method’s precision.
A m m x,r ! 1 ! !
Ax ! 3 ! 1 ! C 1000
m3 A1 Ax ,r m 2
5
m1 = mass of the internal standard in test solution (a), in milligrams,
m2 = mass of the sample in test solution (a), in milligrams,
m3 = mass of the internal standard in reference solution (a), in milligrams,
mx,r = mass of eicosapentaenoic acid ethyl ester CRS or docosahexaenoic acid ethyl ester CRS in
reference solution (a), in milligrams,
Ax = area of the peak corresponding to eicosapentaenoic acid ester or docosahexaenoic acid ester
in the chromatogram obtained with test solution (a),
Ax,r = area of the peak corresponding to eicosapentaenoic acid ester or docosahexaenoic acid ester in
the chromatogram obtained with reference solution (a),
A1 = area of the peak corresponding to the internal standard in the chromatogram obtained with test
solution (a),
A3 = area of the peak corresponding to the internal standard in the chromatogram obtained with ref-
erence solution (a),
C = a conversion factor to fatty acids based on the difference in molecular weight of ethyl esters in
the standard and fatty acid
CEPA = 0.915
CDHA = 0.921
Total omega-3-acids. From the assay for EPA and DHA, calculate the content of the total omega-3-
acids using the following expression and identifying the peaks from the chromatograms:
An !3 ( EPA + DHA)
EPA + DHA +
AEPA + ADHA
EPA = content of EPA obtained from the assay for EPA and DHA,
DHA = content of DHA obtained from the assay for EPA and DHA,
An-3 = sum of the areas of the peaks corresponding to C18:3 n-3, C18:4 n-3, C20:4 n-3, C21:5 n-3
and C22:5 n-3 methyl esters in the chromatogram obtained with test solution (b),
AEPA = area of the peak corresponding to EPA methyl ester in the chromatogram obtained with test
solution (b),
ADHA = area of the peak corresponding to DHA methyl ester in the chromatogram obtained with test
solution (b).